IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB)BioinformaticsPeer-reviewed journal article
CombDNF: Disease-specific drug combination predictions with network-based features on clinically validated data
Abstract
Drug combinations are increasingly applied to treat a wide range of complex diseases. Drug action and thus also drug combination effects can differ between diseases, e.g., due to molecular differences. Therefore, disease-specific predictions are required for treatments. A plethora of methods based on cell-line screening data in cancer has been proposed. However, their extendability to other diseases is limited, as is their applicability in the clinical context due to the in-vivo-in-vitro gap. In contrast, only few approaches rely on clinically validated data. Here, we propose CombDNF, a novel machine-learning based method for disease-specific drug combination prediction on clinically validated data. CombDNF is trained and predicts both on clinically approved (effective) and clinically reported adverse drug combinations from a broad collection of data sources. It can cope with the highly imbalanced label distribution in drug combination data. Further, CombDNF leverages network-derived features based on drug target and disease gene relationships. To incorporate uncertainty of the network topology it relies on edge weights in the underlying network. We systematically evaluate CombDNF against available state-of-the-art methods in four diseases with different underlying mechanisms and ground truth data characteristics. CombDNF outperforms all state-of-the-art methods in all four diseases by at least 84% in the AUPR. This translates, for example, to an enrichment of effective drug combinations in the top ten hypertension-specific predictions of four, compared to one for the best competing method. In addition, network edge weighting by interaction confidence scores indeed yields improved predictions. Further, we find evidence for biological plausibility of our top ranked drug combinations. We make the training and evaluation pipeline for CombDNF available ready-to-use at https://github.com/DILiS-lab/CombDNF.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 31th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Drug-disease networks and drug repurposing
Austin Polanco, Mark E. J. Newman·PLoS Computational BiologyPeer-reviewed·Oct 16, 2025
- DrugCombDB: a comprehensive database of drug combinations toward network medicine and combination therapy
- Personalized anti-cancer drug combination prediction by an Integrated Multi-level Network
Fangyoumin Feng, Zhengtao Zhang, … Hong Li·bioRxiv·May 12, 2020
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations
Arindam Ghosh, Vittorio Fortino·Computational and Structural Biotechnology JournalPeer-reviewed·Dec 7, 2024
- Prediction and principle discovery of drug combination based on multimodal friendship features
Hegang Chen, Xionghui Zhou·bioRxiv·Aug 28, 2024
- DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal
S. Zheng, J. Aldahdooh, … J. Tang·bioRxiv·Mar 25, 2021